Completed

Bromday (Bromfenac Ophthalmic Solution)0.09% QD vs Nevanac (Nepafenac Ophthalmic Suspension) 0.1% TID for Control of Pain and Epithelial Healing Post (PRK)

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being collected

Data Collection

Collected from today forward - Prospective
Who is being recruted

Eye Diseases

+ Myopia

+ Refractive Errors

Over 21 Years
+10 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Observational
Study Start: May 2011
See protocol details

Summary

Principal SponsorVirdi Eye Clinic
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: May 1, 2011

Actual date on which the first participant was enrolled.

This study will compare the effect of two topical non-steroidal antiinflammatory agents to control pain after photorefractive keratectomy (PRK) eye surgery.

Official TitleBromday (Bromfenac Ophthalmic Solution)0.09% QD vs Nevanac (Nepafenac Ophthalmic Suspension) 0.1% TID for Control of Pain and Epithelial Healing Post (PRK)
NCT01475877
Principal SponsorVirdi Eye Clinic
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

20 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 21 Years

Range of ages for which participants are eligible to join.

Healthy volunteers allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Eye DiseasesMyopiaRefractive Errors

Criteria

5 inclusion criteria required to participate
male or female at least 18 years of age,
no other ocular studies with 15 days prior to dosing,
BCVA 20/200 or better,
return for study visits and follow instructions from investigator and staff,
Show More Criteria
5 exclusion criteria prevent from participating
Ocular inflammation,
hypersensitivity to bromfenac or nepafenac,
any corneal pathology,
have had radial keratotomy,
Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Study Objectives

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

Virdi Eye Clinic and Laser Vision Center

Rock Island, United StatesOpen Virdi Eye Clinic and Laser Vision Center in Google Maps
CompletedOne Study Center